4194 Share Price Performance
NT$10.30
-7.05 (-40.63%)
Price NT$10.30
Share PriceNT$10.30
Holy Stone Healthcare Co., Ltd. Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
4194 Community Narratives
There are no narratives available yet.
Recent 4194 News & Updates
Holy Stone Healthcare Co., Ltd. Key Details
Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- -0.96
- Gross Margin
- 20.45%
- Net Profit Margin
- -293.84%
- Debt/Equity Ratio
- 0%
Holy Stone Healthcare Co., Ltd. Competitors
Snowflake Analysis
About 4194
- Founded
- 2001
- Employees
- n/a
- CEO
- WebsiteView website
Holy Stone Healthcare Co., Ltd. develops and sells hyaluronic acid related therapeutic products. in Taiwan. The company offers RenehaVis, a product designed to relive pain and stiffness of the knee joint; SportVis, a treatment to relive the pain and optimize the recovery of tendon and ligament injuries; TRUD, a treatment that allows mucosal tissue to heal naturally and reduces the symptoms of ulcerative colitis; and GAF, a treatment for anal mucosal lesions. It also developing IBD98-M, which is in Phase IIa clinical trials for the treatment of inflammatory bowel diseases; and CA102N to treat colorectal cancer. In addition, the company develops ND108E for the treatment of alzheimer’s disease; AMD112 which is in pre-clinical stage; and CA102L, a novel and small molecule conjugated therapeutic agent to treat lymphoma and multiple myeloma. Holy Stone Healthcare Co., Ltd. was founded in 2001 and is headquartered in Taipei, Taiwan. Holy Stone Healthcare Co., Ltd. is a subsidiary of Holy Stone Enterprise Co.,Ltd.
Market Insight
Rare earths may be a sliver of the global metals market, but they punch far above their weight. These obscure elements are the invisible wiring of modern life.
Continue reading
Taiwanese Market Performance
- 7 Days: 4.4%
- 3 Months: 19.2%
- 1 Year: 16.0%
- Year to Date: 16.2%
Over the last 7 days, the market has risen 4.4%, driven by gains of 6.3% in the Information Technology sector. In the last year, the market has climbed 16%. Earnings are forecast to grow by 18% annually. Market details ›